flecainide has been researched along with ranolazine in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (66.67) | 24.3611 |
| 2020's | 4 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Dalvie, D; Loi, CM; Smith, DA | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Belardinelli, L; Corkey, B; Desai, MC; Dhalla, AK; El-Bizri, N; Elzein, E; Graupe, M; Guerrero, J; Hirakawa, R; Hu, L; Jiang, H; Kahlig, K; Kalla, R; Kobayashi, T; Koltun, DO; Lepist, EI; Li, CH; Li, X; Li, XJ; Liu, G; Lu, Y; Martinez, R; Mollova, N; Murray, B; Notte, GT; Osier, M; Parkhill, EQ; Perry, J; Perry, T; Rajamani, S; Rhodes, G; Saunders, O; Soohoo, D; Strickley, R; Venkataramani, C; Wang, WQ; Xie, C; Zablocki, JA | 1 |
| Belardinelli, L; Crumb, W; Dhalla, AK; El-Bizri, N; Hirakawa, R; Hu, L; Karpinski, S; Koltun, D; Li, CH; Li, XJ; Liu, G; Rajamani, S; Shryock, JC; Smith-Maxwell, C; Wang, WQ; Wu, L; Yao, L; Zablocki, J | 1 |
| Belardinelli, L; Breithardt, G; Eckardt, L; Frommeyer, G; Ghezelbash, S; Milberg, P; Osada, N; Rajamani, S; Razvan, R | 1 |
| Diness, JG; Grunnet, M; Jespersen, T; Kirchhoff, JE; Sheykhzade, M | 1 |
| Akin, I; Behnes, M; Borggrefe, M; Dworacek, J; El-Battrawy, I; Lang, S; Liebe, V; Meister, S; Patocskai, B; Rudic, B; Tiburcy, M; Tülümen, E; Utikal, J; Wieland, T; Yücel, G; Zhao, Z; Zhou, XB; Zimmermann, WH | 1 |
| Bögeholz, N; Eckardt, L; Ellermann, C; Frommeyer, G; Lange, PS; Leitz, P; Puckhaber, D; Wolfes, J | 1 |
| Buhl, R; Jespersen, T; Saljic, A | 1 |
| Li, SY; Lv, TT; Yang, Y; Zhang, P | 1 |
| Kawai, T; Kuninishi, Y; Muraki, Y; Nogawa, H | 1 |
| Bove, T; Cilenti, F; Copetti, R; Cristiani, L; Guglielmo, N; Orso, D; Santangelo, S | 1 |
4 review(s) available for flecainide and ranolazine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Anti-arrhythmic investigations in large animal models of atrial fibrillation.
Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Dogs; Flecainide; Horses; Mammals; Models, Animal; Ranolazine; Swine | 2022 |
Sodium channel blockers in the management of long QT syndrome types 3 and 2: A system review and meta-analysis.
Topics: Adrenergic beta-Antagonists; Electrocardiography; Flecainide; Humans; Long QT Syndrome; Mexiletine; Ranolazine; Sodium Channel Blockers | 2021 |
Bayesian Network Meta-analysis of Randomized Controlled Trials on the Efficacy of Antiarrhythmics in the Pharmacological Cardioversion of Paroxysmal Atrial Fibrillation.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Electric Countershock; Flecainide; Humans; Network Meta-Analysis; Quinidine; Randomized Controlled Trials as Topic; Ranolazine; Systematic Reviews as Topic; Verapamil | 2023 |
8 other study(ies) available for flecainide and ranolazine
| Article | Year |
|---|---|
Which metabolites circulate?
Topics: Humans; Metabolic Clearance Rate; Pharmaceutical Preparations | 2013 |
Discovery of Dihydrobenzoxazepinone (GS-6615) Late Sodium Current Inhibitor (Late I
Topics: | 2016 |
A novel, potent, and selective inhibitor of cardiac late sodium current suppresses experimental arrhythmias.
Topics: Acetanilides; Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiotonic Agents; Cnidarian Venoms; Female; Flecainide; Heart Conduction System; Long QT Syndrome; Mutation; Myocardial Ischemia; Myocytes, Cardiac; Patch-Clamp Techniques; Piperazines; Potassium Channel Blockers; Pyridines; Quaternary Ammonium Compounds; Rabbits; Ranolazine; Sodium Channel Blockers; Triazoles | 2013 |
Sodium channel block by ranolazine in an experimental model of stretch-related atrial fibrillation: prolongation of interatrial conduction time and increase in post-repolarization refractoriness.
Topics: Acetanilides; Administration, Oral; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Female; Flecainide; Heart Conduction System; Heart Rate; In Vitro Techniques; Neural Conduction; Piperazines; Rabbits; Ranolazine; Refractory Period, Electrophysiological; Sodium Channel Blockers; Sotalol; Treatment Outcome | 2013 |
Synergistic antiarrhythmic effect of combining inhibition of Ca²⁺-activated K⁺ (SK) channels and voltage-gated Na⁺ channels in an isolated heart model of atrial fibrillation.
Topics: Acetanilides; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Electrocardiography; Female; Flecainide; Guinea Pigs; Piperazines; Ranolazine; Small-Conductance Calcium-Activated Potassium Channels; Voltage-Gated Sodium Channel Blockers; Voltage-Gated Sodium Channels | 2015 |
Hyperthermia Influences the Effects of Sodium Channel Blocking Drugs in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
Topics: Ajmaline; Flecainide; Hot Temperature; Humans; Lidocaine; Myocytes, Cardiac; Patch-Clamp Techniques; Pluripotent Stem Cells; Polymerase Chain Reaction; Ranolazine; Sodium Channel Blockers; Sodium Channels | 2016 |
Digitalis Promotes Ventricular Arrhythmias in Flecainide- and Ranolazine-Pretreated Hearts.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiotoxicity; Digitalis Glycosides; Drug Interactions; Flecainide; Heart Rate; Isolated Heart Preparation; Ouabain; Rabbits; Ranolazine; Refractory Period, Electrophysiological; Risk Assessment; Time Factors; Voltage-Gated Sodium Channel Blockers | 2019 |
Pharmacological characterisation of electrocardiogram J-T
Topics: Animals; DNA-Binding Proteins; Electrocardiography; Flecainide; Guinea Pigs; Long QT Syndrome; Nifedipine; Quinidine; Quinine; Ranolazine; Sotalol; Torsades de Pointes; Verapamil | 2022 |